active: true
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/c2Fub2ZpLmNvbQ/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/c2Fub2ZpLmNvbQ/images/2025-04-04_logo.svg
cik: '0001121404'
composite_figi: BBG000BBD5N1
currency_name: usd
description: Sanofi develops and markets drugs with a concentration in immunology,
    vaccines, and rare diseases. Although the company offers a diverse array of drugs,
    its highest revenue generator, Dupixent, accounts for approximately 30% of total
    sales. Profits for this immunology blockbuster drug are shared with Regeneron.
    About 45% of total revenue comes from the United States, 20% from Europe, and
    6% from China.
homepage_url: https://www.sanofi.com
list_date: '2002-07-01'
locale: us
market: stocks
market_cap: 118874693799.44
name: Sanofi American Depositary Shares (Each representing one-half of one ordinary
    share)
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG001S5W768
share_class_shares_outstanding: 2460267688
ticker: SNY
ticker_root: SNY
total_employees: 82878
type: ADRC
weighted_shares_outstanding: 2438955556
